WJWM
ABBV icon

Williams Jones Wealth Management’s AbbVie ABBV Stock Holding History

Williams Jones Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Sell
50,099
-147
-0.3% -$31.6K 0.14% 90
2026
Q1 		$10.9M Sell
50,246
-5,152
-9% -$1.14M 0.13% 93
2025
Q4 		$12.7M Sell
55,398
-1,973
-3% -$449K 0.14% 87
2025
Q3 		$13.3M Sell
57,371
-243
-0.4% -$49.5K 0.15% 84
2025
Q2 		$10.7M Sell
57,614
-3,618
-6% -$672K 0.13% 95
2025
Q1 		$12.8M Sell
61,232
-1,120
-2% -$218K 0.16% 88
2024
Q4 		$11.1M Sell
62,352
-975
-2% -$179K 0.13% 96
2024
Q3 		$12.5M Sell
63,327
-7,691
-11% -$1.44M 0.15% 97
2024
Q2 		$12.2M Sell
71,018
-298
-0.4% -$49.4K 0.15% 94
2024
Q1 		$13M Buy
71,316
+167
+0.2% +$28.8K 0.17% 88
2023
Q4 		$11M Buy
71,149
+237
+0.3% +$34.6K 0.15% 93
2023
Q3 		$10.6M Sell
70,912
-1,046
-1% -$154K 0.16% 95
2023
Q2 		$9.69M Sell
71,958
-6,119
-8% -$897K 0.15% 101
2023
Q1 		$12.4M Buy
78,077
+1,694
+2% +$259K 0.19% 90
2022
Q4 		$12.3M Sell
76,383
-1,825
-2% -$280K 0.21% 89
2022
Q3 		$10.5M Buy
78,208
+872
+1% +$125K 0.18% 91
2022
Q2 		$11.8M Buy
77,336
+7,492
+11% +$1.14M 0.19% 91
2022
Q1 		$11.3M Sell
69,844
-2,522
-3% -$366K 0.16% 96
2021
Q4 		$9.8M Buy
72,366
+3,554
+5% +$420K 0.12% 103
2021
Q3 		$7.42M Buy
68,812
+1
+0% +$114 0.1% 116
2021
Q2 		$7.75M Buy
68,811
+128
+0.2% +$14.4K 0.11% 114
2021
Q1 		$7.43M Buy
68,683
+17,846
+35% +$1.91M 0.12% 110
2020
Q4 		$5.45M Buy
50,837
+2,063
+4% +$198K 0.09% 125
2020
Q3 		$4.27M Sell
48,774
-86
-0.2% -$8.1K 0.08% 125
2020
Q2 		$4.8M Buy
48,860
+2,063
+4% +$182K 0.1% 111
2020
Q1 		$3.56M Sell
46,797
-100
-0.2% -$8.52K 0.09% 108
2019
Q4 		$4.15M Sell
46,897
-1,000
-2% -$83K 0.08% 129
2019
Q3 		$3.63M Buy
+47,897
New +$3.28M 0.07% 137

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Williams Jones Wealth Management's ABBV Position: Q2 2026 in Review

Williams Jones Wealth Management reduced its AbbVie (ABBV) stake by 0.29% in Q2 2026, selling an estimated $31.6K and leaving 50,099 shares worth $12.6M. The position accounts for 0.14% of the portfolio, ranked #90.

Williams Jones Wealth Management first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. The position peaked at $13.3M in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Williams Jones Wealth Management held 50,099 shares of AbbVie worth $12.6M as of Q2 2026.
  • Williams Jones Wealth Management sold 147 AbbVie shares in Q2 2026, an estimated $31.6K.
  • AbbVie made up 0.14% of Williams Jones Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Williams Jones Wealth Management first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • Williams Jones Wealth Management's AbbVie position peaked at $13.3M in Q3 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Williams Jones Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.